Literature DB >> 32016322

Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.

Leomar Y Ballester1,2,3, Jeanne M Meis4, Alexander J Lazar4,5, Sujit S Prabhu6, Kimberly B Hoang6, Norman E Leeds7, Gregory N Fuller4.   

Abstract

Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that arises primarily in the extremities of young adults. Recurrent gene fusions involving EWSR1 with members of the cAMP response element binding protein (CREB) family have been reported in a diverse group of tumors, including AFH. AFH-like lesions have been reported to occur intracranially and the reported cases show low proliferation indices, frequently have a connection with the dura, and show recurrent EWSR1 rearrangements. These tumors have been termed intracranial myxoid mesenchymal tumor with EWSR1-CREB family gene fusions. A literature search identified 11 reported cases of intracranial AFH-like lesions with an EWSR1 rearrangement. Here, we report a case of intracranial myxoid mesenchymal tumor with an EWSR1-ATF1 fusion in an adult patient, and review the existing literature on this recently described entity.
© 2020 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  ATF1; Angiomatoid fibrous histiocytoma (AFH); Brain; EWSR1; EWSR1-CREB; Intracranial myxoid mesenchymal tumor

Mesh:

Substances:

Year:  2020        PMID: 32016322     DOI: 10.1093/jnen/nlz140

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  11 in total

1.  Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma.

Authors:  M Adelita Vizcaino; Caterina Giannini; Howard T Chang; Benjamin R Kipp; Karen Fritchie; Rachael Vaubel
Journal:  Brain Tumor Pathol       Date:  2021-01-12       Impact factor: 3.298

2.  Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.

Authors:  Débora Cabral de Carvalho Corrêa; Francine Tesser-Gamba; Indhira Dias Oliveira; Nasjla Saba da Silva; Andrea Maria Capellano; Maria Teresa de Seixas Alves; Patrícia Alessandra Dastoli; Sergio Cavalheiro; Silvia Regina Caminada de Toledo
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-09       Impact factor: 4.553

3.  Cranial angiomatoid fibrous histiocytoma: A case report and review of literature.

Authors:  Amanda E Sion; Rizwan A Tahir; Abir Mukherjee; Jack P Rock
Journal:  Surg Neurol Int       Date:  2020-09-18

4.  Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison with Adult Cases in the Literature.

Authors:  Minami Sasaki; Seiichiro Hirono; Yue Gao; Izumi Suda; Tomoo Matsutani; Masayuki Ota; Takashi Kishimoto; Jun-Ichiro Ikeda; Hideaki Yokoo; Yasuo Iwadate
Journal:  NMC Case Rep J       Date:  2022-05-18

5.  Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report.

Authors:  Louis Garnier; Tanguy Fenouil; Daniel Pissaloux; Roxana Ameli; François Ducray; David Meyronet; Jerome Honnorat
Journal:  Mol Clin Oncol       Date:  2021-05-09

6.  A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes.

Authors:  Arnault Tauziède-Espariat; Gaëlle Pierron; Delphine Guillemot; Philipp Sievers; Dominique Cazals-Hatem; Thierry Faillot; Alexandre Roux; Joseph Benzakoun; Sophie Bockel; Nicolas Weinbreck; Lauren Hasty; Emmanuèle Lechapt; Fabrice Chrétien; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2021-10-29       Impact factor: 7.801

7.  Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates.

Authors:  Josephine K Dermawan; Fabio Vanoli; Laurie Herviou; Yun-Shao Sung; Lei Zhang; Samuel Singer; William D Tap; Ryma Benayed; Tejus A Bale; Jamal K Benhamida; Brendan C Dickson; Cristina R Antonescu
Journal:  Mod Pathol       Date:  2022-03-28       Impact factor: 8.209

8.  Operative Technique: Angiomatoid Fibrous Histiocytoma-Unique Case and Management.

Authors:  David J Mazur-Hart; Brannan E O'Neill; Brandi W Pang; Melanie H Hakar; Matthew D Wood; Sachin Gupta; Christina M Sayama; Jesse J Liu; Aclan Dogan
Journal:  J Neurol Surg Rep       Date:  2022-09-20

9.  Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.

Authors:  Emily A Sloan; Jason Chiang; Javier E Villanueva-Meyer; Sanda Alexandrescu; Jennifer M Eschbacher; Wesley Wang; Manuela Mafra; Nasir Ud Din; Emily Carr-Boyd; Michael Watson; Michael Punsoni; Angelica Oviedo; Ahmed Gilani; Bette K Kleinschmidt-DeMasters; Dylan J Coss; M Beatriz Lopes; Corey Raffel; Mitchel S Berger; Susan M Chang; Alyssa Reddy; Biswarathan Ramani; Sean P Ferris; Julieann C Lee; Jeffrey W Hofmann; Soo-Jin Cho; Andrew E Horvai; Melike Pekmezci; Tarik Tihan; Andrew W Bollen; Fausto J Rodriguez; David W Ellison; Arie Perry; David A Solomon
Journal:  Brain Pathol       Date:  2021-01-28       Impact factor: 6.508

10.  An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.

Authors:  Arnault Tauziède-Espariat; Philipp Sievers; Frédérique Larousserie; Joseph Benzakoun; Delphine Guillemot; Gaëlle Pierron; Mathilde Duchesne; Emmanuelle Uro-Coste; Alexandre Roux; Alexandre Vasiljevic; Tanguy Fenouil; David Meyronet; Karima Mokhtari; Marc Polivka; Audrey Rousseau; Frédérique Bost-Bezeaud; Samir Akoury; Johan Pallud; Chiara Benevello; Lauren Hasty; Albane Gareton; Emmanuèle Lechapt; Fabrice Chrétien; Thomas Blauwblomme; Kévin Beccaria; Stéphanie Puget; Felix Sahm; Pascale Varlet
Journal:  Brain Pathol       Date:  2021-07-27       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.